Definitive Contract 75F40124C00086

Award Date 8/8/24
Potential Completion Date 8/15/25
Potential Value $326K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
8(a) Sole Source
Extent Competed
Not Available for Competition
Major Defense Program
Not listed
Pricing Type
Labor Hours
Place of Performance
Ivins, UT, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed

This is a 1-year labor hour (LH) type contract awarded by the Food and Drug Administration (FDA) to Kaiva Strategies, LLC, an 8(a) sole source certified small disadvantaged business, to provide Microsoft 365 Developer Level III services for the FDA's Center for Drug Evaluation and Research (CDER), Office of Generic Drugs (OGD). The contract has a ceiling value of $326,246.40 and runs through August 15, 2025. Kaiva Strategies is a tribally-owned, minority-owned small business that specializes in professional services such as medical writing, scientific writing, and public health infrastructure support for federal health agencies like the FDA and CDC. The company holds multiple small business certifications, including 8(a) and HUBZone status, which have enabled it to secure prime contract awards through set-aside programs. This contract is part of a larger $100 million single-award Indefinite Delivery Contract (IDC) that Kaiva Strategies holds with the FDA to provide a broad range of professional, administrative, and consulting services.

Generated 8/9/24, 9:19 AM